Clinical role of apolipoproteins A and B-Reference-Cited by-同舟云学术

Clinical role of apolipoproteins A and B

Published:2011-12-20 Issue:6 Volume:10 Page:105-111
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Chumakova G. A.¹,Gritsenko O. V.²,Veselovskaya N. G.³,Vakhromeeva E. V.⁴,Kozarenko A. A.¹

Affiliation:

1. Altay State Medical University, Barnaul; Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo

2. Altay State Medical University, Barnaul

3. Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo; Altay Region Cardiology Dispanser, Barnaul

4. Altay Region Cardiology Dispanser, Barnaul

Abstract

The assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipoprotein (Apo) A, ApoB, and their ratio.Lower ApoB/ApoAI ratio values denote lower levels of cardiovascular risk.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference63 articles.

1. Mathieu P, Pibarot P, Després J-P. Metabolic Syndrome: The Danger Signal in Atherosclerosis. Vasc Health Risk Manag 2006; 2(3): 285-302.

2. Olofsson S-O, Wiklund O, Borén J. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag 2007; 3(4): 491-502.

3. Baroni MG, Berni A, Romeo S, et al. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med Genet 2003; 4: 8.

4. Rukovodstvo po aterosklerozu i ishemicheskoi bolezni serdtsa. Pod redaktsiei akad Chazova E.I., chl.- kor. RAMN Kukh6archuka V.V., prof. S.A.Boitsova. M.: “MEDIAMEDICA” 2007; 736 s.

5. Gazi I, Tsimihodimos V, Filippatos TD, et al. LDL cholesterol estimation in patients with the metabolic syndrome. Lipids Health Dis 2006; 5: 8.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of the severity of the early formation of the atherosclerotic process in certain pathological forms of coronary heart disease in marine specialists in the conditions of the Arctic region;Arctic and Innovations;2024-06-16

2. Hypolipidemic Action of Medicinal Plant Extracts for Experimental Diabetes Mellitus;Pharmaceutical Chemistry Journal;2019-06-15